SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,499.17 -455.59
( -0.58%)

Global Indices

Nasdaq

53,904.84 -465.28
(-0.86%)

Dow Jones

7,729.00 -15.55
(-0.20%)

Hang Seng

65,597.55 -85.71
(-0.13%)

Nikkei 225

10,873.25 -15.05
(-0.14%)

Forex

USD-INR

95.07 -0.16
(-0.17%)

EUR-INR

109.74 0.07
(0.06%)

GBP-INR

127.99 0.00
(0.00%)

JPY-INR

0.60 0.00
(-0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

423.3622252

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

36.34

119157.18

EPS(TTM)

Face Value()

Div & Yield %

40.59

0.88

Back

Sampann Utpadan India consolidated net profit rises 12.02% in the June 2026 quarter

Jul 29,2026

Net profit of Sampann Utpadan India rose 12.02% to Rs 2.05 crore in the quarter ended June 2026 as against Rs 1.83 crore during the previous quarter ended June 2025. Sales rose 27.60% to Rs 41.70 crore in the quarter ended June 2026 as against Rs 32.68 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	41.70	32.68	28
OPM %	11.01	12.27	-
PBDT	4.30	3.89	11
PBT	2.75	2.44	13
NP	2.05	1.83	12

78,499.17 -455.59 ( -0.58%)

53,904.84 -465.28 (-0.86%)

7,729.00 -15.55 (-0.20%)

65,597.55 -85.71 (-0.13%)

10,873.25 -15.05 (-0.14%)

95.07 -0.16 (-0.17%)

109.74 0.07 (0.06%)

127.99 0.00 (0.00%)

0.60 0.00 (-0.16%)